ClinicalTrials.Veeva

Menu

Meningioma and Embolism Thrombosis Risk & Investigation of Coagulation (001_2024_BO2)

U

University Hospital Tuebingen

Status

Enrolling

Conditions

Surgical Resection
Meningeoma
Thrombembolism

Study type

Observational

Funder types

Other

Identifiers

NCT06709833
001_2024_BO2

Details and patient eligibility

About

Despite being generally benign tumors, meningiomas are associated with an increased risk for thrombembolic complications after surgical resection. The molecular mechanisms underlying this circumstance are still unknown.

In this prospective observational trial, the investigators aim to evaluate the changes in coagulation and platelet function caused by tumor resection.

Blood samples are obtained by patients undergoing meningioma resection before and immediately after resection to detect said changes.

As a control cohort, blood samples are obtained from patients undergoing resection for glioma.

Enrollment

100 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Patients undergoing resection for meningioma or
  • Patients undergoing resection for glioma or
  • Healthy controls
  • written consent for study participation

Exclusion criteria

Trial design

100 participants in 3 patient groups

Meningioma resection
Description:
patients undergoing resection for meningioma
Glioma resection
Description:
Patients undergoing glioma resection as a control cohort for meningioma patients
Healthy controls
Description:
Healthy controls without tumor and surgical resection

Trial contacts and locations

1

Loading...

Central trial contact

Michael Koeppen, MD; Alice Bernard, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems